|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
DE229046T1
(de)
|
1985-03-30 |
1987-12-17 |
Marc Genf/Geneve Ballivet |
Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren.
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
|
US5681718A
(en)
|
1986-03-14 |
1997-10-28 |
Celltech Limited |
Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
|
FI915411A7
(fi)
|
1989-05-16 |
1991-11-15 |
Scripps Research Inst |
Heteromeeristen reseptorien koe-ekspressio
|
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
|
US5183884A
(en)
|
1989-12-01 |
1993-02-02 |
United States Of America |
Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
WO1992003918A1
(en)
|
1990-08-29 |
1992-03-19 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
DK0564531T3
(da)
|
1990-12-03 |
1998-09-28 |
Genentech Inc |
Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber
|
|
CA2103059C
(en)
|
1991-06-14 |
2005-03-22 |
Paul J. Carter |
Method for making humanized antibodies
|
|
DE69233745D1
(de)
|
1991-12-02 |
2008-10-23 |
Cambridge Antibody Tech |
Herstellung von Autoantikörpern auf Phagenoberflächen ausgehend von Antikörpersegmentbibliotheken
|
|
EP1291360A1
(en)
|
1991-12-13 |
2003-03-12 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
DK1143006T3
(da)
|
1995-08-18 |
2008-07-14 |
Morphosys Ip Gmbh |
Vektorer/DNA-sekvenser fra humane kombinatoriske antistofbiblioteker
|
|
US7264963B1
(en)
|
1995-08-18 |
2007-09-04 |
Morphosys Ag |
Protein(poly)peptide libraries
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
US5968511A
(en)
|
1996-03-27 |
1999-10-19 |
Genentech, Inc. |
ErbB3 antibodies
|
|
PT896586E
(pt)
*
|
1996-03-27 |
2007-01-31 |
Genentech Inc |
Anticorpos de erbb3
|
|
US5804968A
(en)
|
1997-01-29 |
1998-09-08 |
Picker International, Inc. |
Gradient coils with reduced eddy currents
|
|
US20030105057A1
(en)
|
1997-03-19 |
2003-06-05 |
Yale University |
Methods and compositions for stimulating apoptosis and cell death or for inhibiting cell growth and cell attachment
|
|
EP0998486B2
(en)
|
1997-06-13 |
2012-02-01 |
Genentech, Inc. |
Protein recovery by chromatography followed by filtration upon a charged layer
|
|
US6417168B1
(en)
|
1998-03-04 |
2002-07-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods of treating tumors
|
|
ZA200007412B
(en)
|
1998-05-15 |
2002-03-12 |
Imclone Systems Inc |
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases.
|
|
AUPQ105799A0
(en)
|
1999-06-18 |
1999-07-08 |
Victor Chang Cardiac Research Institute, The |
Cell growth inhibition
|
|
BRPI0012198B8
(pt)
|
1999-06-25 |
2021-05-25 |
Genentech Inc |
anticorpos humanizados, composição e imunoconjugado
|
|
DE60044997D1
(de)
|
1999-07-02 |
2010-11-04 |
Morphosys Ag |
Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
|
|
US7390632B2
(en)
|
1999-09-30 |
2008-06-24 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 receptor isoforms
|
|
US7097840B2
(en)
|
2000-03-16 |
2006-08-29 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
|
AU2001264696B2
(en)
|
2000-05-19 |
2007-01-04 |
Genentech, Inc. |
Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy
|
|
US7658921B2
(en)
|
2000-12-12 |
2010-02-09 |
Medimmune, Llc |
Molecules with extended half-lives, compositions and uses thereof
|
|
EP1355919B1
(en)
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
|
EP1228766A1
(en)
|
2001-01-31 |
2002-08-07 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
PYK2 phosphorylation by HER3 induces tumor invasion
|
|
US20040116330A1
(en)
|
2001-04-27 |
2004-06-17 |
Kenichiro Naito |
Preventive/therapeutic method for cancer
|
|
WO2002087619A1
(en)
|
2001-04-27 |
2002-11-07 |
Takeda Chemical Industries, Ltd. |
Preventive/therapeutic method for cancer
|
|
US7744882B2
(en)
|
2001-05-31 |
2010-06-29 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 methods of detection and antibodies
|
|
US7638302B2
(en)
|
2001-05-31 |
2009-12-29 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 receptor isoforms
|
|
EP2277542B1
(en)
|
2001-06-01 |
2014-04-16 |
Cornell Research Foundation Inc. |
Modified antibodies to prostrate-specific membrane antigen and uses thereof
|
|
KR100945108B1
(ko)
|
2001-06-13 |
2010-03-02 |
젠맵 에이/에스 |
표피 성장 인자 수용체 (egfr)에 대한 인간모노클로날 항체
|
|
IL159177A0
(en)
|
2001-06-20 |
2004-06-01 |
Prochon Biotech Ltd |
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
|
|
US7125680B2
(en)
|
2001-07-27 |
2006-10-24 |
The Regents Of The University Of California |
Methods and materials for characterizing and modulating interaction between heregulin and HER3
|
|
US7662374B2
(en)
|
2001-08-03 |
2010-02-16 |
The Trustees Of The University Of Pennsylvania |
Monoclonal antibodies to activated erbB family members and methods of use thereof
|
|
EP1283053A1
(en)
|
2001-08-09 |
2003-02-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibitors of HER3 activity
|
|
EP2048154B2
(en)
|
2002-02-05 |
2015-06-03 |
Genentech, Inc. |
Protein purification
|
|
US7591994B2
(en)
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
|
TWI350285B
(en)
|
2002-03-13 |
2011-10-11 |
Array Biopharma Inc |
N3 alkylated benzimidazole derivatives as mek inhibitors
|
|
CA2480099C
(en)
|
2002-03-26 |
2019-01-08 |
Zensun (Shanghai) Sci-Tech. Ltd. |
Erbb3 based methods and compositions for treating neoplasms
|
|
US7332580B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The University Of California |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
WO2003102132A2
(en)
|
2002-04-26 |
2003-12-11 |
Genetech, Inc. |
Non-affinity purification of proteins
|
|
US20040229299A1
(en)
|
2002-05-21 |
2004-11-18 |
Badal M. Youssouf |
Intracellular complexes as biomarkers
|
|
US20040229293A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
Surface receptor complexes as biomarkers
|
|
US7402397B2
(en)
|
2002-05-21 |
2008-07-22 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
|
US20040229380A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB heterodimers as biomarkers
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
AT413486B
(de)
|
2002-07-03 |
2006-03-15 |
Igeneon Krebs Immuntherapie |
Verwendung eines antikörpers gerichtet gegen lewis-antigene
|
|
AU2003273218C1
(en)
|
2002-07-15 |
2019-01-17 |
F. Hoffmann - La Roche Ag |
Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies
|
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
|
AU2003258061A1
(en)
|
2002-08-02 |
2004-02-23 |
Salmedix, Inc. |
Therapeutic inhibitionof protein kinases in cancer cells
|
|
US20060067947A1
(en)
|
2002-09-19 |
2006-03-30 |
Orient Cancer Therapy Co., Ltd. |
Immunotherapeutic for cancer
|
|
SI1578446T1
(sl)
|
2002-11-07 |
2015-07-31 |
Immunogen, Inc. |
Protitelesa proti-cd33 in metoda za zdravljenje akutne mieloidne levkemije z uporabo istega
|
|
WO2004065417A2
(en)
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
|
WO2004076621A2
(en)
|
2003-02-27 |
2004-09-10 |
Yeda Research And Development Co. Ltd. |
Compositions of nucleic acids for treating and detecting influenza virus
|
|
KR101224235B1
(ko)
|
2003-04-11 |
2013-01-25 |
메디뮨 엘엘씨 |
재조합 il9 항체 및 그의 용도
|
|
TW568408U
(en)
|
2003-05-14 |
2003-12-21 |
High Tech Comp Corp |
Slide structure
|
|
CN1972712A
(zh)
|
2003-06-09 |
2007-05-30 |
塞缪尔·瓦克萨尔 |
用胞外拮抗物和胞内拮抗物抑制受体酪氨酸激酶的方法
|
|
EP1493445A1
(en)
|
2003-07-04 |
2005-01-05 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibition of stress-induced ligand-dependent EGFR activation
|
|
CA2531595C
(en)
|
2003-07-28 |
2015-12-08 |
Genentech, Inc. |
Reducing protein a leaching during protein a affinity chromatography
|
|
EP1653986A4
(en)
|
2003-08-01 |
2007-03-14 |
Smithkline Beecham Corp |
TREATMENT OF CANCERS EXPRESSING P95 SP ERBB2 / SP
|
|
JP2007510708A
(ja)
|
2003-11-06 |
2007-04-26 |
ファイザー・プロダクツ・インク |
癌の治療における選択的erbB2阻害剤/抗erbB抗体の組合せ
|
|
WO2005075514A2
(en)
|
2004-03-10 |
2005-08-18 |
Lonza Ltd. |
Method for producing antibodies
|
|
JP4969440B2
(ja)
|
2004-04-08 |
2012-07-04 |
デビッド, ビー. エイガス, |
疼痛治療のためのErbBアンタゴニスト
|
|
CN1997382A
(zh)
|
2004-05-05 |
2007-07-11 |
梅里麦克制药股份有限公司 |
调节生物活性的双特异性结合剂
|
|
WO2006024497A1
(en)
|
2004-08-30 |
2006-03-09 |
Lonza Biologics Plc. |
Affinity- plus ion exchange- chromatography for purifying antibodies
|
|
AU2005294347A1
(en)
|
2004-10-05 |
2006-04-20 |
Oregon Health And Science University |
Compositions and methods for treating disease
|
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
US20070009972A1
(en)
|
2005-02-16 |
2007-01-11 |
Ginger Chao |
Epidermal growth factor receptor polypeptides and antibodies
|
|
CA2596133C
(en)
|
2005-02-23 |
2016-11-15 |
Genentech, Inc. |
Extending time to disease progression or survival in cancer patients
|
|
JP2008535795A
(ja)
|
2005-03-07 |
2008-09-04 |
ターゲッティド・モレキュラー・ダイアグナスティクス・エルエルシー |
チロシンキナーゼインヒビター組成物、並びに疾患の治療におけるそれらの製造及び使用のための方法
|
|
WO2006133460A2
(en)
|
2005-06-09 |
2006-12-14 |
Yale University |
Methods for diagnosing and treating breast cancer based on a her/er ratio
|
|
PE20070207A1
(es)
|
2005-07-22 |
2007-03-09 |
Genentech Inc |
Tratamiento combinado de los tumores que expresan el her
|
|
CN101309933A
(zh)
*
|
2005-09-07 |
2008-11-19 |
米迪缪尼有限公司 |
毒素偶联的Eph受体抗体
|
|
WO2007030642A2
(en)
|
2005-09-07 |
2007-03-15 |
Medimmune, Inc. |
Toxin conjugated eph receptor antibodies
|
|
TWI405756B
(zh)
|
2005-12-21 |
2013-08-21 |
Array Biopharma Inc |
新穎硫酸氫鹽
|
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
|
US8399442B2
(en)
|
2005-12-30 |
2013-03-19 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
WO2007115571A2
(en)
|
2006-04-07 |
2007-10-18 |
Enkam Pharmaceuticals A/S |
Erbb receptor-derived peptide fragments
|
|
CA2639070A1
(en)
|
2006-04-13 |
2007-11-01 |
Oncomethylime Sciences S.A. |
Novel tumour suppressor
|
|
AU2007353412A1
(en)
|
2006-11-21 |
2008-11-20 |
Fox Chase Cancer Center |
Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof
|
|
EP2518508A1
(en)
|
2006-11-28 |
2012-10-31 |
U3 Pharma GmbH |
Activated HER3 as a marker for predicting therapeutic efficacy
|
|
US8652466B2
(en)
|
2006-12-08 |
2014-02-18 |
Macrogenics, Inc. |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
|
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US7825127B2
(en)
|
2006-12-28 |
2010-11-02 |
Takeda Pharmaceutical Company, Limited |
Method for treating cancer
|
|
WO2008081331A2
(en)
|
2006-12-29 |
2008-07-10 |
Sinomab Bioscience Limited |
Enhancing the level of antibody expression by framework re-engineering
|
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
|
KR101598229B1
(ko)
|
2007-02-16 |
2016-02-26 |
메리맥 파마슈티컬즈, 인크. |
Erbb3에 대한 항체 및 이의 용도
|
|
CA2677108A1
(en)
|
2007-03-02 |
2008-09-12 |
Genentech, Inc. |
Predicting response to a her inhibitor
|
|
US9155753B2
(en)
|
2007-03-09 |
2015-10-13 |
Geron Corporation |
Treatment of carcinomas with a combination of EGF-pathway and telomerase inhibitors
|
|
EP2139924B1
(en)
|
2007-03-29 |
2016-07-06 |
Genmab A/S |
Bispecific antibodies and methods for production thereof
|
|
AU2008239594B2
(en)
|
2007-04-13 |
2013-10-24 |
Beth Israel Deaconess Medical Center |
Methods for treating cancer resistant to ErbB therapeutics
|
|
US20090258005A1
(en)
|
2007-05-29 |
2009-10-15 |
Trubion Pharmaceuticals Inc. |
Therapeutic compositions and methods
|
|
US20110091473A1
(en)
|
2007-10-22 |
2011-04-21 |
Genmab A/S |
Novel antibody therapies
|
|
MX2010005783A
(es)
*
|
2007-11-27 |
2010-08-10 |
Ablynx Nv |
Secuencias de aminoacidos dirigidas contra citoquinas heterodimericas y/o sus receptores y polipeptidos que comprenden las mismas.
|
|
WO2009092014A1
(en)
|
2008-01-18 |
2009-07-23 |
Gagnon Peter S |
Enhanced purification of antibodies and antibody fragments by apatite chromatography
|
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
|
US20110027296A1
(en)
|
2008-04-09 |
2011-02-03 |
Universidad De Barcelona |
Antibodies for treating cancer
|
|
EP2860260A1
(en)
|
2008-04-11 |
2015-04-15 |
Merrimack Pharmaceuticals, Inc. |
Human serum albumin linkers and conjugates thereof
|
|
WO2009157919A1
(en)
|
2008-06-23 |
2009-12-30 |
Tumor Biology Investment Group, Inc. |
SOLUBLE ErbB3 DETECTION, REGULATION AND TREATMENT OF CANCER
|
|
EP2138511A1
(en)
*
|
2008-06-27 |
2009-12-30 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
HER3 as a determinant for the prognosis of melanoma
|
|
EP2159836B1
(en)
|
2008-08-25 |
2017-05-31 |
Soitec |
Stiffening layers for the relaxation of strained layers
|
|
EA201170660A1
(ru)
|
2008-11-07 |
2011-12-30 |
Сантарис Фарма А/С |
Избирательная для erbb-3 (her3) комбинированная терапия
|
|
US20110020327A1
(en)
|
2008-12-16 |
2011-01-27 |
Millipore Corporation |
Purification of proteins
|
|
EP2401621B1
(en)
|
2009-02-24 |
2013-08-14 |
Roche Diagnostics GmbH |
Use of s-erbb-3 as a marker for cancer
|
|
NZ594665A
(en)
|
2009-03-20 |
2013-08-30 |
Genentech Inc |
Bispecific anti-her antibodies
|
|
CA2759233C
(en)
|
2009-04-27 |
2019-07-16 |
Oncomed Pharmaceuticals, Inc. |
Method for making heteromultimeric molecules
|
|
US8362215B2
(en)
|
2009-04-29 |
2013-01-29 |
Trellis Bioscience, Llc |
Antibodies immunoreactive with heregulin-coupled HER3
|
|
WO2011001276A1
(en)
|
2009-06-30 |
2011-01-06 |
Philogen S.P.A. |
Immunocytokines in combination with anti-erbb antibodies for the treatment of cancer
|
|
WO2011019620A1
(en)
|
2009-08-10 |
2011-02-17 |
Genentech, Inc. |
Antibodies with enhanced adcc function
|
|
EP2486052A4
(en)
*
|
2009-10-09 |
2013-05-01 |
Merck Sharp & Dohme |
GENERATION, LABELING AND USE OF ANTI-HER3 ANTIBODIES
|
|
WO2011047180A1
(en)
|
2009-10-14 |
2011-04-21 |
Merrimack Pharmaceuticals, Inc. |
Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof
|
|
PL2719708T3
(pl)
|
2009-11-13 |
2018-04-30 |
Daiichi Sankyo Europe Gmbh |
Materiał i sposoby leczenia lub zapobiegania chorobom związanym z HER-3
|
|
NZ600262A
(en)
*
|
2009-12-22 |
2013-06-28 |
Roche Glycart Ag |
Anti-her3 antibodies and uses thereof
|
|
SG183532A1
(en)
|
2010-03-11 |
2012-09-27 |
Merrimack Pharmaceuticals Inc |
Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers
|
|
US8481687B2
(en)
*
|
2010-04-09 |
2013-07-09 |
Aveo Pharmaceuticals, Inc. |
Anti-ErbB3 antibodies
|
|
WO2011153383A1
(en)
|
2010-06-04 |
2011-12-08 |
Bipar Science, Inc. |
Methods of treating platinum-resistant recurrent ovarian cancer with 4-iodo-3-nitrobenzamide in combination with an anti-metabolite and a platinum compound
|
|
WO2012019024A2
(en)
|
2010-08-04 |
2012-02-09 |
Immunogen, Inc. |
Her3-binding molecules and immunoconjugates thereof
|
|
WO2012018404A2
(en)
|
2010-08-06 |
2012-02-09 |
U3 Pharma Gmbh |
Use of her3 binding agents in prostate treatment
|
|
PH12013500333A1
(en)
|
2010-08-20 |
2013-04-22 |
Novartis Ag |
Antibodies for epidermal growth factor receptor 3 (her3)
|
|
TW201302793A
(zh)
|
2010-09-03 |
2013-01-16 |
Glaxo Group Ltd |
新穎之抗原結合蛋白
|
|
JP5995851B2
(ja)
|
2010-10-18 |
2016-09-21 |
メディアファーマ エス. アール. エル.Mediapharma S. R. L. |
ErbB3結合抗体
|
|
MX347981B
(es)
|
2010-11-01 |
2017-05-22 |
Symphogen As |
Composicion de anticuerpos pan-her.
|
|
US20150231238A1
(en)
|
2011-03-15 |
2015-08-20 |
Merrimack Pharmaceuticals, Inc. |
Overcoming resistance to erbb pathway inhibitors
|
|
CN103781800A
(zh)
|
2011-06-20 |
2014-05-07 |
协和发酵麒麟株式会社 |
抗erbB3抗体
|
|
HK1200468A1
(en)
|
2011-09-30 |
2015-08-07 |
Regeneron Pharmaceuticals, Inc. |
Anti-erbb3 antibodies and uses thereof
|
|
WO2013071058A1
(en)
|
2011-11-09 |
2013-05-16 |
The Uab Research Foundation |
Her3 antibodies and uses thereof
|
|
WO2013078191A1
(en)
|
2011-11-23 |
2013-05-30 |
Medimmune, Llc |
Binding molecules specific for her3 and uses thereof
|
|
ES2758433T3
(es)
|
2011-12-05 |
2020-05-05 |
Novartis Ag |
Anticuerpos contra el receptor 3 del factor de crecimiento epidérmico (HER3)
|
|
CA2868034C
(en)
|
2012-03-29 |
2021-07-27 |
Shire Human Genetic Therapies, Inc. |
Ionizable cationic lipids
|
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
|
US11305012B2
(en)
*
|
2013-09-24 |
2022-04-19 |
Medimmune, Llc |
Binding molecules specific for HER3 and uses thereof
|
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
|
US10745490B2
(en)
*
|
2014-04-11 |
2020-08-18 |
Celldex Therapeutics, Inc. |
Anti-ErbB antibodies and methods of use thereof
|
|
EP3191128A4
(en)
|
2014-09-11 |
2018-03-14 |
Celldex Therapeutics, Inc. |
Uses of anti-her3 antibodies for treating cancer
|
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|